Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Cadrenal Therapeutics (NASDAQ: CVKD): CMO Resignation Raises Leadership Questions Ahead of Phase 3

Chief Medical Officers play a central role in clinical-stage biotech companies, typically overseeing trial design, regulatory strategy, and the medical and scientific narrative the company presents to investors, physicians, and agencies like the FDA. A CMO departure ahead of major trial milestones can introduce …

Nitish Kishor | 13 July 2026

Autonomix Medical (NASDAQ: AMIX): Canadian Patent Win Expands Neural Sensing IP Portfolio

Endoscopic sympathectomy refers to a minimally invasive procedure targeting the sympathetic nervous system, which regulates a wide array of involuntary bodily functions including heart rate, blood pressure, and pain signaling. Autonomix's platform is designed to combine sensing technology — which can detect and map …

Nitish Kishor | 13 July 2026

Armata Pharmaceuticals (NYSE American: ARMP): FDA Pediatric Agreement Clears Path for Phase 3 Staph Trial

PREA generally requires companies developing new drugs to study their safety and effectiveness in pediatric populations, but it also recognizes that testing unproven therapies in children before adult data are available can raise ethical and safety concerns, particularly for serious, high-mortality conditions like bacteremia. …

Nitish Kishor | 13 July 2026

ENvue Medical (NASDAQ: FEED): AI-Driven Robotic Prototype Targets Automated Feeding Tube Placement

Feeding tube placement is a common but clinically important procedure, particularly for hospitalized patients who cannot safely take food or medication orally. Incorrect placement carries real risks, including tubes migrating into the airway rather than the digestive tract, which is why real-time navigation and …

Nitish Kishor | 13 July 2026

Immutep Limited (NASDAQ: IMMP): INSIGHT-003 Survival Data Tops Historical Benchmark in Lung Cancer

Overall survival is widely considered the gold-standard endpoint in oncology clinical trials, since it directly measures whether a treatment helps patients live longer rather than relying on surrogate markers like tumor response rate or progression-free survival. A nearly nine-month improvement over historical benchmarks, if …

Nitish Kishor | 13 July 2026

Immutep Limited (NASDAQ: IMMP): Company Launches Forensic Probe Into Halted TACTI-004 Trial

TACTI-004 was designed to evaluate eftilagimod alfa (efti) in combination with pembrolizumab and chemotherapy in a larger, pivotal-stage NSCLC population, building on encouraging earlier-stage data for the drug. The trial's discontinuation followed disappointing results, but the nature of those results — specifically a suppressed …

Nitish Kishor | 13 July 2026

California Resources Corporation Discloses Q2 2026 Realized Oil Prices and $190 Million Commodity Derivative Loss

California Resources Corporation, the Long Beach-based independent oil and gas producer, released preliminary and unaudited summary data on July 14, 2026, covering realized commodity prices and derivative settlements for the three months ended June 30, 2026. The disclosure reveals that the company's realized oil …

Aakashdeep | 13 July 2026

Is Sunda Energy Well Positioned for Higher Oil and Gas Prices?

Sunda Energy PLC (LSE:SNDA) is an AIM-listed oil and gas exploration and development company focused on building a diversified upstream energy portfolio across the Asia-Pacific region. The company has exploration, appraisal and production interests in Timor-Leste, the Philippines and New Zealand. Its strategy is …

Ankur Sharma | 13 July 2026

US Markets Turn Cautious as Middle East Tensions Lift Oil, Yields and the Dollar

US equities closed higher on Friday ahead of earnings season, with the S&P 500 gaining 0.4%, the Nasdaq 100 rising 0.3% and the Dow adding 150 points. Sentiment was supported by SK Hynix’s strong US market debut, gains in Nvidia, AMD and Meta, and …

Team Kalkine | 13 July 2026

SBA Communications Announces New Senior Notes Offering Aimed at Debt Repayment

SBA Communications Corporation has announced a new offering of senior notes due in 2030, 2031, and 2033, according to a recent filing. The company aims to use the proceeds to repay existing debts, including a 2024 Term Loan and borrowings under its Revolving Credit …

Aditi Sarkar | 13 July 2026
Support

Hi! How can we help you today?

Loading…